Drug Type Nanobody |
Synonyms NM-04 |
Target |
Action inhibitors |
Mechanism PTK7 inhibitors(Protein-tyrosine kinase 7 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Preclinical | China | 12 Oct 2022 | |
Uterine Cervical Cancer | Preclinical | United States | 12 Oct 2022 |